Navigation Links
NJBIZ Honors New Jersey's General Counsels
Date:4/1/2013

WOODCLIFF LAKE, N.J., April 1, 2013 /PRNewswire/ -- Martin L. Wilson, Chief Counsel, Compliance & Litigation, has been named a finalist in the Corporate Compliance Professional category in the 2013 NJBIZ General Counsel of the Year Awards program.  The award program, produced by NJBIZ, New Jersey's premiere business news publication, is sponsored by Nicoll Davis & Spinella LLP, Real Estate Strategies, Update Discovery, Gibbons P.C., Archer & Greiner P.C., K&L Gates, Budd Larner , and Deloitte.  

The General Counsel of the Year Awards program honors New Jersey's standout General Counsels, Chief Legal Officers and corporate compliance professionals for the critical role they play in making their companies successful.  Finalists were selected in six categories: Public Company with revenues up to $1 Billion, Public Company with revenues of more than $1 Billion, Corporate Compliance Professional, Private Company with revenues up to $1 Billion, Private Company with revenues of more than $1 Billion, and Non-profit or Government Organization. 

Finalists and winners were chosen by an independent panel of judges including: Mayor Gerald R. Drasheff , Christine Pellizzari , Christopher Klein , and Anthony Tinari .  Honorees were selected using a scoring system based on: career successes, legal victories and achievements, professional services provided and community service. 

The General Counsel of the Year Awards finalists will be recognized and the winners in each category will be announced during a breakfast awards ceremony on Thursday, June 6, 2013 at the Palace in Somerset Park in Somerset, NJ. 

For more information about the NJBIZ General Counsel of the Year Awards program or to reserve seats to the event, please visit www.njbiz.com/events or contact Melissa Sullenberger at melissas@njbiz.com or (732) 246-5737.  

About Par Pharmaceutical Companies, Inc. 

Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
2. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
3. GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
4. Frost & Sullivan Honors Acuo Technologies with 2012 Market Share Leadership Award in Enterprise Imaging Informatics
5. iSALUS Healthcares chairman receives national honors from Samaritans Purse - an international organization providing spiritual and physical aid to victims of war, poverty, natural disaster and disease.
6. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
7. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
8. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
11. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):